In recent years, atherosclerotic diseases including ischaemic heart disease have become important causes of death in patients with gout. A previous in vitro study' demonstrated that uric acid provokes the proliferation of vascular smooth muscle cells, resulting in arteriosclerosis. However, it remains undetermined whether or not hyperuricaemia per se is an independent risk factor for arteriosclerosis. In contrast, it is well known that lipid abnormalities such as hypercholesterolaemia, decreased concentrations of high density lipoprotein cholesterol (HDL-C), hypertriglyceridaemia and increased serum apolipoprotein B concentrations are important risk factors for atherosclerosis. Previous studies have demonstrated that serum concentrations of both triglyceride and apolipoprotein B were greater in patients with gout than in normal subjects, while HDL-C was decreased in patients with goUt.2 3 Thus gout patients share some of the characteristics of the so called ' 
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tMedian and range; other values mean (SE). Lp(a) = Lp(a) lipoprotein; HDL-C = high density lipoprotein cholesterol; Apo = apolipoprotein; NS = not significant. 
